Semaglutide vs. GLP-1 Medications: Brand Names and Types Explained

Medical disclaimer: This article is for general education only. It is not medical advice and is not a substitute for care from your healthcare provider. GLP-1 and GLP-1-related medications are prescription medications. Your prescriber should guide decisions about which medication is right for you, your dose, side effects, medication changes, and any concerns about your treatment plan.

If you have spent any time reading about GLP-1 medications, you have probably seen a long list of names: Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, Saxenda, Victoza, and more.

It can get confusing quickly.

Some names are brand names. Some are active ingredients. Some medications use the same active ingredient but are approved for different uses. Some are related to GLP-1 medications but work through more than one hormone pathway.

So if you have wondered whether Ozempic and Wegovy are the same thing, whether Mounjaro is a GLP-1, or why your experience looks nothing like someone else’s, you are not alone.

Here is the plain-English version.

First, what is semaglutide?

Semaglutide is the generic name for a medication that acts on GLP-1 receptors in the body.

GLP-1 stands for glucagon-like peptide-1. It is a hormone your body naturally makes after you eat. GLP-1 helps regulate appetite, fullness, digestion, insulin, glucagon, and blood sugar.

Semaglutide is a GLP-1 receptor agonist. That means it activates GLP-1 receptors and mimics some of the effects of your body’s natural GLP-1 hormone, but in a longer-lasting way.

Semaglutide is the active ingredient. Ozempic, Wegovy, and Rybelsus are brand names.

This is one of the most important distinctions.

Semaglutide is the active ingredient.

Ozempic, Wegovy, and Rybelsus are brand names for medications that contain semaglutide.

They are not exactly interchangeable, because they can differ by approved use, dose, form, and instructions. But they do share the same active ingredient.

Here is the simple breakdown:

The main takeaway: Ozempic, Wegovy, and Rybelsus all contain semaglutide, but they are not the same prescription. Your prescriber should guide which medication, dose, and form apply to you.

What about Mounjaro and Zepbound?

Mounjaro and Zepbound do not contain semaglutide.

They contain tirzepatide.

Tirzepatide is related to GLP-1 medications, but it is not the same molecule as semaglutide. It works through two hormone pathways: GIP and GLP-1.

That is why tirzepatide is often called a dual GIP and GLP-1 receptor agonist.

Here is the simple breakdown:

People often talk about Mounjaro and Zepbound alongside GLP-1 medications because they activate GLP-1 receptors and can affect appetite, fullness, digestion, and blood sugar. But technically, tirzepatide is a dual agonist, not a GLP-1-only medication.

Are there other GLP-1 medications?

Yes. Semaglutide and tirzepatide get a lot of attention, but they are not the only medications in this broader category.

Other GLP-1 receptor agonists include:

This article focuses mostly on semaglutide and tirzepatide because they are the names many new GLP-1 users hear most often. But the larger category includes several medications with different active ingredients, dosing schedules, and approved uses.

Why are there so many different names?

There are a few reasons.

First, medications have both active ingredient names and brand names. The active ingredient is the drug itself. The brand name is the product name used by the company that makes it.

Second, the same active ingredient can be approved under different brand names for different uses. That is why semaglutide can appear as Ozempic, Wegovy, or Rybelsus.

Third, different medications may target similar systems in different ways. Semaglutide activates GLP-1 receptors. Tirzepatide activates both GIP and GLP-1 receptors. Other GLP-1 receptor agonists may differ in how often they are taken, how long they last, and what uses they are approved for.

Fourth, approvals can change over time as new clinical trials are completed. A medication may first be approved for type 2 diabetes, then later receive additional approvals for other uses in certain groups of people.

That is why it is always important to confirm medication-specific questions with your prescriber or the official prescribing information, not just social media or a friend’s experience.

Why your friend’s GLP-1 experience may look different from yours

Even when two people take the same medication, their experiences can be very different.

One person may feel appetite changes quickly. Another may notice a gradual shift. One person may have nausea early on. Another may have very few side effects. One person may lose weight steadily. Another may have slower changes or a plateau.

That does not automatically mean someone is doing it right or wrong.

There are many reasons people respond differently, including:

• The specific medication.
• The dose.
• How quickly the dose changes.
• How sensitive the person is to slower digestion.
• Eating patterns.
• Hydration.
• Constipation or nausea.
• Sleep.
• Stress.
• Activity level.
• Other medications.
• Medical history.
• Individual biology.

Newer research also suggests genetics may play a role in how some people respond to GLP-1 and GLP-1-related medications. Variations in genes related to GLP-1 and GIP receptors have been associated with differences in weight response and side effects such as nausea or vomiting.

That does not mean genetic testing is currently the standard way to choose a GLP-1 medication. It does mean that individual response is not just about effort, discipline, or willpower. Biology matters.

Why medication names can feel emotionally loaded

For many people, these medication names are not just technical details. They come with expectations.

Maybe you heard that one medication “works better.” Maybe someone told you they had no side effects. Maybe a friend lost weight faster than you. Maybe you are on one brand and wondering whether you should be on another.

That comparison can get stressful quickly.

But brand names do not tell the whole story. Your response depends on your body, your prescription, your dose, your side effects, your routines, and your care plan.

The goal is not to match someone else’s experience. The goal is to understand your own experience well enough to know what is changing, what feels manageable, and what is worth bringing up with your healthcare provider.

Where Glo fits in

Glo was built for exactly this kind of confusion.

The moment when you are not sure whether Ozempic and Wegovy are the same active ingredient.

The moment when you hear Mounjaro called a GLP-1 and wonder why someone else says it is different.

The moment when your friend’s side effects, appetite, or progress look nothing like yours.

The moment when you want to track what is happening so you can have a clearer conversation with your provider.

Glo supports people using doctor-prescribed GLP-1 and GLP-1-related medications. Glo does not prescribe medication, recommend medication changes, or replace your healthcare provider. But Glo can help you understand medication terms in plain language, track day-to-day patterns, and organize what you are experiencing between appointments.

The bottom line

Semaglutide is an active ingredient. Ozempic, Wegovy, and Rybelsus are brand names that contain semaglutide.

Tirzepatide is a different active ingredient. Mounjaro and Zepbound contain tirzepatide, which activates both GIP and GLP-1 receptors.

Other GLP-1 medications exist too, including liraglutide, dulaglutide, and exenatide products.

The names are confusing, but the big idea is simple: medication names, active ingredients, approved uses, and individual responses are not all the same thing.

Understanding the difference can help you feel more informed, ask better questions, and navigate your GLP-1 journey with more confidence.